Cytovale Stock
Cytovale is a medical technology company focused on developing rapid diagnostics for sepsis and other immune-mediated diseases. Using a proprietary technology based on cell mechanics and microfluidics, Cytovale measures immune cell activity to enable early detection and treatment of conditions like sepsis, significantly improving patient outcomes.
Founded: 2013
For more Cytovale stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Ajay Shah Chief Executive Officer and Co-Founder |
| Henry Tse Chief Technology Officer and Co-Founder |
| Bill Blackledge Chief Financial Officer |
| Christopher Slachta Chief Operating Officer |
